Skip to main content
Journal cover image

Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.

Publication ,  Journal Article
Browning, DJ; Yokogawa, N; Greenberg, PB; Perlman, E
Published in: Am J Ophthalmol
February 2021

Duke Scholars

Published In

Am J Ophthalmol

DOI

EISSN

1879-1891

Publication Date

February 2021

Volume

222

Start / End Page

400 / 401

Location

United States

Related Subject Headings

  • Retinal Diseases
  • Ophthalmology & Optometry
  • Mass Screening
  • Hydroxychloroquine
  • Humans
  • Antirheumatic Agents
  • 3212 Ophthalmology and optometry
  • 1117 Public Health and Health Services
  • 1113 Opthalmology and Optometry
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Browning, D. J., Yokogawa, N., Greenberg, P. B., & Perlman, E. (2021). Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol, 222, 400–401. https://doi.org/10.1016/j.ajo.2020.09.015
Browning, David J., Naoto Yokogawa, Paul B. Greenberg, and Elliot Perlman. “Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.Am J Ophthalmol 222 (February 2021): 400–401. https://doi.org/10.1016/j.ajo.2020.09.015.
Browning DJ, Yokogawa N, Greenberg PB, Perlman E. Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol. 2021 Feb;222:400–1.
Browning, David J., et al. “Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.Am J Ophthalmol, vol. 222, Feb. 2021, pp. 400–01. Pubmed, doi:10.1016/j.ajo.2020.09.015.
Browning DJ, Yokogawa N, Greenberg PB, Perlman E. Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol. 2021 Feb;222:400–401.
Journal cover image

Published In

Am J Ophthalmol

DOI

EISSN

1879-1891

Publication Date

February 2021

Volume

222

Start / End Page

400 / 401

Location

United States

Related Subject Headings

  • Retinal Diseases
  • Ophthalmology & Optometry
  • Mass Screening
  • Hydroxychloroquine
  • Humans
  • Antirheumatic Agents
  • 3212 Ophthalmology and optometry
  • 1117 Public Health and Health Services
  • 1113 Opthalmology and Optometry
  • 1103 Clinical Sciences